Success of Big Infectious Disease Reimbursement Policy in China
Dados Bibliográficos
| ID | 13775883 |
|---|---|
| Autores | Kun-xi Nie (Shihezi University, Guangzhou, P.R. China), Chan Wang (0000-0002-1442-8484, Guangdong University of Finance & Economics, Guangzhou, P.R. China, autor correspondente), Xinwu Li (0000-0002-0953-3618, Guangdong University of Finance), Xin-wu Li (Guangdong University of Finance & Economics, Guangzhou, P.R. China) |
| Ano | 2020 |
| Volume | 57 |
| Páginas | 46958020907788-46958020907788 |
| Data de publicação | 2020-01-01 |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | INQUIRY The Journal of Health Care Organization Provision and Financing (JOURNAL) |
| Identificadores do periódico | ISSN: 0046-9580 • E-ISSN: 1945-7243 |
| Editora | SAGE Publishing (PUBLISHER • US) |
| DOI | 10.1177/0046958020907788 |
| PMID | 32075479 |
| OpenAlex | W3007690905 |
| Idioma | EN |
| Citações recebidas | 1 |
| Referências citadas | 14 |
Big infectious diseases do harm to the whole society, and it is highly crucial to control them on time. The major purpose of this article is to theoretically demonstrate that the Chinese government's intervention in large-scale infectious diseases is successful and efficient. Two potential strategies were considered: strategy 1 was infectious disease without government intervention, and strategy 2 was infectious disease with government intervention. By evolution model, this article illustrates the efficiency of big infectious disease reimbursement policy in China. Without government reimbursement, this article finds that high expenditures accelerate the disease infection. The number of infected persons decreases under big infectious disease reimbursement policy in China. The higher the treatment costs, the more important the government intervention. Big infectious disease reimbursement policy in China can serve as an efficient example to cope with big infectious diseases
Big government · Business · China · Disease · Economic growth · Economic interventionism · Economics · Government (linguistics · Harm · Health care · Infectious disease (medical specialty · Intensive care medicine · Intervention (counseling · Political science · Reimbursement · COVID-19 epidemiological studies · Law · Medicine · Nursing · Vaccine Coverage and Hesitancy · Zoonotic diseases and public health
A contribution to the mathematical theory of epidemics
Big Data Analytics, Infectious Diseases and Associated Ethical Impacts
Predicting Infectious Disease Using Deep Learning and Big Data
Effects of asymmetric medical insurance subsidy on hospitals competition under non-price regulation
Reimbursement and hospital competition in China
The Economical Control of Infectious Diseases
| Citações por ano | 0,25 |
|---|---|
| Intervalo de citações | 2022 - 2022 (1) |
| Altamente citado | Não |